Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design

Jamie A Jarusiewicz1, Satoshi Yoshimura2, Anand Mayasundari1

  • 1Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, United States.

Summary

New phenyl dihydrouracil (PD)-based Proteolysis Targeting Chimeras (PROTACs) offer enhanced chemical stability and protein degradation efficacy compared to traditional thalidomide analogues. These PD-PROTACs overcome limitations of previous designs, improving cellular potency.